Skip to main content
Premium Trial:

Request an Annual Quote

Millipore, Guava to Integrate Flow Cytometry Reagents, Instrumentation

NEW YORK (GenomeWeb News) - Millipore and Guava Technologies have agreed to integrate their flow cytometry instrumentation, reagents, and support capabilities in an effort to target cell biologists, the companies said today.
 
Under the terms of the partnership, Millipore will develop co-branded reagent kits for Guava's flow cytometers. Millipore also has exclusive rights to distribute and service Guava's non-clinical instrumentation within certain regions of North America, Europe, and Asia.
 
The companies said they also plan to “work together to develop a new generation of instrumentation with enhanced performance and functionality.”
 
The first co-branded products under the partnership will be released in July.
 
Guava specializes in micro-capillary flow cytometry systems, which require smaller sample volumes, generate less waste, have lower operating costs, and are easier to set up and run than traditional flow cytometry technology, according to the company.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.